Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats
Initial pipeline comprised of two monoclonal antibodies that show broad and significant neutralization of emerging SARS-CoV-2 variants; data posted on BioRXiv...
Source: prnewswire.com